317 related articles for article (PubMed ID: 28805015)
1. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
[TBL] [Abstract][Full Text] [Related]
2. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
Maurer B; Reich N; Juengel A; Kriegsmann J; Gay RE; Schett G; Michel BA; Gay S; Distler JH; Distler O
Ann Rheum Dis; 2012 Aug; 71(8):1382-7. PubMed ID: 22523431
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.
Tsujino K; Reed NI; Atakilit A; Ren X; Sheppard D
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L22-L31. PubMed ID: 27864286
[TBL] [Abstract][Full Text] [Related]
5. Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension.
Biasin V; Marsh LM; Egemnazarov B; Wilhelm J; Ghanim B; Klepetko W; Wygrecka M; Olschewski H; Eferl R; Olschewski A; Kwapiszewska G
J Pathol; 2014 May; 233(1):7-17. PubMed ID: 24258247
[TBL] [Abstract][Full Text] [Related]
6. Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.
Avouac J; Konstantinova I; Guignabert C; Pezet S; Sadoine J; Guilbert T; Cauvet A; Tu L; Luccarini JM; Junien JL; Broqua P; Allanore Y
Ann Rheum Dis; 2017 Nov; 76(11):1931-1940. PubMed ID: 28801346
[TBL] [Abstract][Full Text] [Related]
7. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
Huang J; Maier C; Zhang Y; Soare A; Dees C; Beyer C; Harre U; Chen CW; Distler O; Schett G; Wollin L; Distler JHW
Ann Rheum Dis; 2017 Nov; 76(11):1941-1948. PubMed ID: 28814429
[TBL] [Abstract][Full Text] [Related]
8. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.
Avouac J; Cagnard N; Distler JH; Schoindre Y; Ruiz B; Couraud PO; Uzan G; Boileau C; Chiocchia G; Allanore Y
Arthritis Rheum; 2011 Nov; 63(11):3552-62. PubMed ID: 21769840
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
10. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
11. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of fractalkine and mobilisation of CD34
Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
[TBL] [Abstract][Full Text] [Related]
13. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyopathy in murine models of systemic sclerosis.
Venalis P; Kumánovics G; Schulze-Koops H; Distler A; Dees C; Zerr P; Palumbo-Zerr K; Czirják L; Mackevic Z; Lundberg IE; Distler O; Schett G; Distler JH
Arthritis Rheumatol; 2015 Feb; 67(2):508-16. PubMed ID: 25371068
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.
Mendoza FA; Piera-Velazquez S; Farber JL; Feghali-Bostwick C; Jiménez SA
Arthritis Rheumatol; 2016 Jan; 68(1):210-7. PubMed ID: 26360820
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous Pulmonary Hypertension Associated With Systemic Sclerosis in P-Selectin Glycoprotein Ligand 1-Deficient Mice.
González-Tajuelo R; de la Fuente-Fernández M; Morales-Cano D; Muñoz-Callejas A; González-Sánchez E; Silván J; Serrador JM; Cadenas S; Barreira B; Espartero-Santos M; Gamallo C; Vicente-Rabaneda EF; Castañeda S; Pérez-Vizcaíno F; Cogolludo Á; Jiménez-Borreguero LJ; Urzainqui A
Arthritis Rheumatol; 2020 Mar; 72(3):477-487. PubMed ID: 31509349
[TBL] [Abstract][Full Text] [Related]
17. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis.
Cauvet A; Decellas A; Guignabert C; Rongvaux-Gaïda D; Thuillet R; Ottaviani M; Tu L; Rieger F; Avouac J; Allanore Y
Arthritis Res Ther; 2023 Sep; 25(1):167. PubMed ID: 37700377
[TBL] [Abstract][Full Text] [Related]
19. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
[TBL] [Abstract][Full Text] [Related]
20. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.
Hsu E; Shi H; Jordan RM; Lyons-Weiler J; Pilewski JM; Feghali-Bostwick CA
Arthritis Rheum; 2011 Mar; 63(3):783-94. PubMed ID: 21360508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]